The Economics of Cancer Care

May 31 from 12:30 PM-5:00 PM and June 1 from 7:30 AM-11:00 AM
McCormick Place, Room S102

Seminar Description

Oncology professionals are practicing in an increasingly complex economic landscape, with pressures from several different areas. There is much discussion regarding treatment costs, impacting both practice sustainability and patient financial burden, as well as how to reward therapeutic innovation while managing development costs. Innovative reimbursement, coverage, and treatment models provide lessons learned and new best practices, and the base of data in this area is rapidly expanding. All of this coupled with clinical trial costs and trends in overall cancer treatment spending have resulted in wealth of information to examine and assimilate into individual research and practice decisions. This seminar provides learners with relevant information regarding all of these topics, so they can make better-informed decisions in their relations with patients, payers and others.

This seminar is approved for physician credits. Additional information regarding CME credits is listed below.

Seminar Agenda

Note: Session faculty will be added to the agenda below as presenters are confirmed.

Day 1: Thursday, May 31, 2018: 12:30 PM - 5:00 PM

12:30 PM - 1:00 PM Lunch
1:00 PM - 2:55 PM 

Session 1: Financial Toxicity—How Costs Negatively Impact Patients and What Can Be Done About It?

 

Cost and Financial Hardship

 

Limiting Therapy in End-of-Life Care

 

Do Patients Want to Discuss Cost with Their Oncologists?

 

The New Expensive Thearpies and Their Inherent Costs

 

Patient/Patient Advocate Perspective on Financial Toxicity and Cost

 

Panel Question and Answer 

2:55 PM - 3:05 PM Break
3:05 PM - 5:00 PM

Session 2: All About the Drugs

 

An Overview of the National Academy's Recommendation on Drug Access

 

A Global Perspective on Drug Reimbursement

 

Discussions of Market Regulations and the Effects on Global Capital Markets

 

Insurance and the Cost of Drugs for Patients

 

Panel Question and Answer

 

Day 2: Friday, June 1, 2018: 7:00 AM - 11:00 AM

7:00 AM - 7:30 AM Breakfast
7:30 AM - 8:50 AM

Session 3: TBD

8:50 AM - 9:00 AM Break
9:00 AM - 11:00 AM

Session 4: Payment Models and Innovations in Cancer Care Delivery

 

Maryland's All-Payer Model

 

Paying for Cancer Care from the State Perspective

 

What is the Role of Value Based Insurance Design in Cancer Care?

 

An Evaluator's Perspective on the Oncology Care Model

 

Panel Question and Answer

 

Seminar Committee

View Seminar Committee Disclosures

Elad Sharon, MD, MPH (Chair)​
National Cancer Institute

Rena M. Conti, PhD​
University of Chicago

John Vernon Cox, DO, FACP, FASCO, MBA
Parkland Health System/UTSW

Stacie Dusetzina, PhD
Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill

Richard Sullivan, PhD
King's Health Partners Cancer Center

Robin Yabroff, PhD
US Department of Health and Human Services

Accreditation 

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Target Audience

The 2018 Economics of Cancer Care Seminar is designed for the cancer care team; credit is offered for physicians, but all are encouraged to participate, as they may be able to apply for credit through their own licensing organization.

Disclaimer/Unlabeled Usage Statement         

The information presented is that of the contributing authors and does not necessarily represent the views of the American Society of Clinical Oncology and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated. Therefore, before prescribing any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions and adverse effects.